These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9226479)

  • 1. Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury.
    Lazarus DD; Kambayashi T; Yato-Kioka M; Baumann H; Jacob CO; Strassmann G
    Int J Immunopharmacol; 1997 Jan; 19(1):49-58. PubMed ID: 9226479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CD4 cross-linking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion.
    Oyaizu N; McCloskey TW; Than S; Pahwa S
    Blood; 1996 Mar; 87(6):2361-8. PubMed ID: 8630399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
    Ksontini R; Colagiovanni DB; Josephs MD; Edwards CK; Tannahill CL; Solorzano CC; Norman J; Denham W; Clare-Salzler M; MacKay SL; Moldawer LL
    J Immunol; 1998 Apr; 160(8):4082-9. PubMed ID: 9558119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha.
    Künstle G; Leist M; Uhlig S; Revesz L; Feifel R; MacKenzie A; Wendel A
    Immunol Lett; 1997 Jan; 55(1):5-10. PubMed ID: 9093874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesnarinone is a selective inhibitor of macrophage TNF(alpha) release.
    Kambayashi T; Mazurek N; Jacob CO; Wei N; Fong M; Strassmann G
    Int J Immunopharmacol; 1996; 18(6-7):371-8. PubMed ID: 9024938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
    Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
    Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in mice.
    Shirin H; Bruck R; Aeed H; Hershkoviz R; Lider O; Kenet G; Avni Y; Halpern Z
    Liver; 1997 Dec; 17(6):275-80. PubMed ID: 9455732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse islet cell lysis mediated by interleukin-1-induced Fas.
    Yamada K; Takane-Gyotoku N; Yuan X; Ichikawa F; Inada C; Nonaka K
    Diabetologia; 1996 Nov; 39(11):1306-12. PubMed ID: 8932996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 Jun; 164(11):5815-25. PubMed ID: 10820260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.
    Matsumori A; Shioi T; Yamada T; Matsui S; Sasayama S
    Circulation; 1994 Mar; 89(3):955-8. PubMed ID: 8124835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells.
    Biburger M; Tiegs G
    J Immunol; 2005 Aug; 175(3):1540-50. PubMed ID: 16034092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1--relevance for concanavalin A-induced hepatitis.
    Wolf D; Hallmann R; Sass G; Sixt M; Küsters S; Fregien B; Trautwein C; Tiegs G
    J Immunol; 2001 Jan; 166(2):1300-7. PubMed ID: 11145713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.
    Küsters S; Gantner F; Künstle G; Tiegs G
    Gastroenterology; 1996 Aug; 111(2):462-71. PubMed ID: 8690213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against concanavalin A-induced murine liver injury by the organic germanium compound, propagermanium.
    Ishiwata Y; Yokochi S; Hashimoto H; Ninomiya F; Suzuki T
    Scand J Immunol; 1998 Dec; 48(6):605-14. PubMed ID: 9874494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury.
    Ryu KH; Kim SY; Kim YR; Woo SY; Sung SH; Kim HS; Jung SC; Jo I; Park JW
    Exp Cell Res; 2014 Aug; 326(1):143-54. PubMed ID: 24954408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
    Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Fas ligand to T cell-mediated hepatic injury in mice.
    Seino K; Kayagaki N; Takeda K; Fukao K; Okumura K; Yagita H
    Gastroenterology; 1997 Oct; 113(4):1315-22. PubMed ID: 9322527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial.
    Deswal A; Petersen NJ; Feldman AM; White BG; Mann DL
    Chest; 2001 Aug; 120(2):453-9. PubMed ID: 11502643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis.
    Jiang H; Bielekova B; Okazaki H; Clarence-Smith K; Johnson KP; Bergey G; Martin R; Dhib-Jalbut S
    J Neuroimmunol; 1999 Jun; 97(1-2):134-45. PubMed ID: 10408967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
    Tsutsui H; Matsui K; Kawada N; Hyodo Y; Hayashi N; Okamura H; Higashino K; Nakanishi K
    J Immunol; 1997 Oct; 159(8):3961-7. PubMed ID: 9378984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.